FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2550191569> ?p ?o ?g. }

• W2550191569 abstract "Background Gout is a chronic inflammatory disorder associated with elevated levels of serum uric acid (sUA), resulting in urate crystal deposits in soft tissues. Uncontrolled gout can lead to bone erosion and joint destruction, kidney stones, and uric acid nephropathy. Gout is treatable with medication and lifestyle change. Long-term sUA monitoring is needed to confirm that patients are achieving target levels (≤6 mg/dL, or 1–3 Objectives To describe incident gout cases and characterize these patients by subsequent sUA testing practices during 5 consecutive years. Methods Data from Clalit Health Services were used to identify incident cases of gout (1/1/2003–31/12/2009) among members ≥25 years old with continuous enrollment in Clalit for 1 year prior to and 5 years subsequent to diagnosis (index date). Cases were identified based on the following criteria: a) 1 diagnosis of gout from a hospital or specialist visit; or b) ≥2 diagnoses of gout from a general practitioner (GP) visit and either elevated sUA (>6 mg/dL) or a purchase of colchicine or allopurinol. Cases were excluded if a member was concurrently diagnosed with a disease known to affect sUA (eg, renal insufficiency, cancer, Familial Mediterranean Fever). sUA testing practices during the 5-year follow-up period were defined as: full (≥1 test per year), moderate (≥1 test per year for 3 or 4 years), poor (≥1 test per year for 1 or 2 years) and no testing (no tests performed). Demographics, clinical characteristics, comorbidities, concurrent medications, and healthcare utilization were examined and stratified by testing practices. Chi-square tests and one-way ANOVAs were used to test for differences by testing practices. Results We identified 15,598 incident gout cases meeting the inclusion criteria. Mean age was 59.3±14.5 years, 79.7% were male, and 35.7% were of higher socioeconomic status. Patients9 clinical history indicated that 15.2% were current smokers and 32.4% were obese. Prevalence of pre-existing comorbidities including CVD, diabetes and hypertension was 26.8%, 20.8%, and 52.5% respectively, and mean Charlson Comorbidity Index was 0.9±1.3. The distribution of annual sUA testing over the 5-year follow up in this cohort was: 5,445 (34.9%) patients had full testing, 6,678 (42.8%) had moderate testing, 3,196 (20.5%) had poor testing, and 279 (1.8%) had no testing. At the end of follow-up, 25.6% of patients9 last documented sUA was ≤6 mg/dL. Among patients in the groups with sUA ≤6 or ≥10 mg/dL, close to 39% had full testing, while among those with sUA between 6.1–9.9 mg/dL, full testing ranged from 31.6%–35.7%. Conclusions Consistent with previous findings, gout patients in Clalit were on average older adults, predominately men and with concurrent comorbidities. Over three-quarters of newly diagnosed gout patients performed an annual sUA testing during at least 3 of the 5 years of follow-up. Further study is required to assess the association between regular testing and health outcomes. References Khanna, et al. Arthritis Care Res. 2012;64(10):1431–46; Zhang et al. Ann Rheum Dis 2006;65:1213–24; Jordan et al. Rheumatology 2007;46(8):1372–4. Acknowledgement Study funded by AstraZeneca. Disclosure of Interest A. Benis Employee of: Clalit Health Services, D. Jaffe Employee of: Kantar Health, N. Flores Employee of: Kantar Health, H. Gabay Employee of: Clalit Health Services, R. Morlock Employee of: Ardea Biosciences, A. Klein Employee of: AstraZeneca, D. Teltsch Employee of: Evidera, J. Chapnick Employee of: Kantar Health, B. Feldman Employee of: Clalit Health Services, M. Leventer-Roberts Employee of: Clalit Health Services" @default.
• W2550191569 created "2016-11-30" @default.
• W2550191569 creator A5000223218 @default.
• W2550191569 creator A5032395280 @default.
• W2550191569 creator A5042337225 @default.
• W2550191569 creator A5044373538 @default.
• W2550191569 creator A5046824138 @default.
• W2550191569 creator A5047307940 @default.
• W2550191569 creator A5068667883 @default.
• W2550191569 creator A5069475033 @default.
• W2550191569 creator A5084522362 @default.
• W2550191569 creator A5091629822 @default.
• W2550191569 date "2016-06-01" @default.
• W2550191569 modified "2023-09-28" @default.
• W2550191569 title "FRI0564 Serum Uric Acid Testing Practices over Five Years among Incident Gout Cases" @default.
• W2550191569 doi "https://doi.org/10.1136/annrheumdis-2016-eular.3895" @default.
• W2550191569 hasPublicationYear "2016" @default.
• W2550191569 type Work @default.
• W2550191569 sameAs 2550191569 @default.
• W2550191569 citedByCount "0" @default.
• W2550191569 crossrefType "journal-article" @default.
• W2550191569 hasAuthorship W2550191569A5000223218 @default.
• W2550191569 hasAuthorship W2550191569A5032395280 @default.
• W2550191569 hasAuthorship W2550191569A5042337225 @default.
• W2550191569 hasAuthorship W2550191569A5044373538 @default.
• W2550191569 hasAuthorship W2550191569A5046824138 @default.
• W2550191569 hasAuthorship W2550191569A5047307940 @default.
• W2550191569 hasAuthorship W2550191569A5068667883 @default.
• W2550191569 hasAuthorship W2550191569A5069475033 @default.
• W2550191569 hasAuthorship W2550191569A5084522362 @default.
• W2550191569 hasAuthorship W2550191569A5091629822 @default.
• W2550191569 hasConcept C126322002 @default.
• W2550191569 hasConcept C141071460 @default.
• W2550191569 hasConcept C187212893 @default.
• W2550191569 hasConcept C2778653478 @default.
• W2550191569 hasConcept C2779134260 @default.
• W2550191569 hasConcept C2779537928 @default.
• W2550191569 hasConcept C2779721657 @default.
• W2550191569 hasConcept C2779881121 @default.
• W2550191569 hasConcept C2780261098 @default.
• W2550191569 hasConcept C2780402116 @default.
• W2550191569 hasConcept C2780932893 @default.
• W2550191569 hasConcept C71924100 @default.
• W2550191569 hasConceptScore W2550191569C126322002 @default.
• W2550191569 hasConceptScore W2550191569C141071460 @default.
• W2550191569 hasConceptScore W2550191569C187212893 @default.
• W2550191569 hasConceptScore W2550191569C2778653478 @default.
• W2550191569 hasConceptScore W2550191569C2779134260 @default.
• W2550191569 hasConceptScore W2550191569C2779537928 @default.
• W2550191569 hasConceptScore W2550191569C2779721657 @default.
• W2550191569 hasConceptScore W2550191569C2779881121 @default.
• W2550191569 hasConceptScore W2550191569C2780261098 @default.
• W2550191569 hasConceptScore W2550191569C2780402116 @default.
• W2550191569 hasConceptScore W2550191569C2780932893 @default.
• W2550191569 hasConceptScore W2550191569C71924100 @default.
• W2550191569 hasLocation W25501915691 @default.
• W2550191569 hasOpenAccess W2550191569 @default.
• W2550191569 hasPrimaryLocation W25501915691 @default.
• W2550191569 hasRelatedWork W1870845963 @default.
• W2550191569 hasRelatedWork W1973295648 @default.
• W2550191569 hasRelatedWork W2068413898 @default.
• W2550191569 hasRelatedWork W2103608778 @default.
• W2550191569 hasRelatedWork W2185402750 @default.
• W2550191569 hasRelatedWork W2319442175 @default.
• W2550191569 hasRelatedWork W2321272238 @default.
• W2550191569 hasRelatedWork W2412762464 @default.
• W2550191569 hasRelatedWork W2755084638 @default.
• W2550191569 hasRelatedWork W2755687766 @default.
• W2550191569 hasRelatedWork W2889221384 @default.
• W2550191569 hasRelatedWork W2909148245 @default.
• W2550191569 hasRelatedWork W2910502067 @default.
• W2550191569 hasRelatedWork W2949476952 @default.
• W2550191569 hasRelatedWork W2949760676 @default.
• W2550191569 hasRelatedWork W2951790146 @default.
• W2550191569 hasRelatedWork W2952841694 @default.
• W2550191569 hasRelatedWork W3035895890 @default.
• W2550191569 hasRelatedWork W3047072196 @default.
• W2550191569 hasRelatedWork W3165694690 @default.
• W2550191569 isParatext "false" @default.
• W2550191569 isRetracted "false" @default.
• W2550191569 magId "2550191569" @default.
• W2550191569 workType "article" @default.